O-003

Oxymorphone-D₃ solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

• 经验公式（希尔记法）: C₁₇H₁₆NO₄D₃
• CAS号: 145225-03-2
• 分子量: 304.36
• EC號碼: 200-659-6
• MDL號碼: MFCD00673302
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329818812
• NACRES: NA.24

属性

• 等級: certified reference material
• 品質等級: 300
• 形狀: liquid
• 特點: Snap-N-Spike^®/Snap-N-Shoot^®
• 包裝: ampule of 1 mL
• 製造商／商標名: Cerilliant^®
• drug control: Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
• 濃度: 100 μg/mL in methanol
• 技術: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 應用: forensics and toxicology
• 格式: single component solution
• 儲存溫度: −20°C
• SMILES 字串: [2H]C([2H])([2H])N1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CCC4=O)c35
• InChI: 1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1/i1D3
• InChI 密鑰: UQCNKQCJZOAFTQ-ZXTOONLTSA-N

说明

一般說明

A stable-labeled internal standard suitable for quantitation of oxymorphone levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, pain prescription monitoring, clinical toxicology, forensic analysis or pharmaceutical research. Oxymorphone, sold under trade names such as Opana^®, Numorphan^®, and Numorphone, is an opiate analgesic indicated for the relief of moderate to severe pain.

應用

• Photoluminescence sensor development: Oxymorphone-D3 solution was utilized in the creation of a photoluminescence sensor for metal detection, incorporating symmetrical ligands on a porous silicon surface, demonstrating its application in analytical methodologies for environmental monitoring and material analysis (Saleem et al., 2024).
• Healthcare budget impact analysis: In a study examining the economic implications of healthcare treatments, Oxymorphone-D3 solution was mentioned as part of a broader analysis on budget impacts, showcasing its relevance in pharmaceutical economics and decision-making processes within healthcare management (Wilson et al., 2024).
• Co-solvency and drug solubilization research: Research on drug solubilization techniques referred to the use of Oxymorphone-D3 solution to study the combined effects of co-solvency and inclusion complex formation, providing insights into formulation science and bioavailability enhancement in pharmaceutical development (Dehghan et al., 2024).

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Numorphan is a registered trademark of Endo Pharmaceuticals Inc.

Opana is a registered trademark of Endo Pharmaceuticals Inc.

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

安全信息

• 象形圖: GHS02,GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H225,H301 + H311 + H331,H370
• 防範說明: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• 危險分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• 標靶器官: Eyes
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 1
• 閃點（°F）: 49.5 °F - closed cup
• 閃點（°C）: 9.7 °C - closed cup